UB Paderborn / Katalog / Suche / in CDI

Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia

Leukemia, 2015-04, Vol.29 (4), p.877-885

2015

Volltextzugriff (PDF)

The impact of SF3B1 mutations in CLL on the DNA-damage response

Leukemia, 2015-05, Vol.29 (5), p.1133-1142

2015

Volltextzugriff (PDF)

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia

Leukemia, 2012-07, Vol.26 (7), p.1458-1461

2012

Volltextzugriff (PDF)

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting

Haematologica (Roma), 2015-03, Vol.100 (3), p.370

2015

Volltextzugriff (PDF)

miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities

Leukemia, 2009-06, Vol.23 (6), p.1159-1163

2009

Volltextzugriff (PDF)

The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2020, Vol.33 (1), p.32

2020

Volltextzugriff (PDF)

TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations

Leukemia, 2010-12, Vol.24 (12), p.2072-2079

2010

Volltextzugriff (PDF)

Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification

Cell death & disease, 2015-08, Vol.6 (8), p.e1852-e1852

2015

Volltextzugriff (PDF)

613 Clonal Selection of TP53 Mutations in Chronic Lymphocytic Leukaemia Detected by Ultra-deep Pyrosequencing

European journal of cancer (1990), 2012-07, Vol.48, p.S146-S146

2012

Volltextzugriff (PDF)

885 P53 Mutations Affecting DNA-binding Have Prominent Impact on Survival in Chronic Lymphocytic Leukemia

European journal of cancer (1990), 2012-07, Vol.48, p.S214-S214

2012

Volltextzugriff (PDF)

Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment

Leukemia, 2006-06, Vol.20 (6), p.1159-1161

2006

Volltextzugriff (PDF)

Potent induction of wild-type p53-dependent transcription in tumour cells by a synthetic inhibitor of cyclin-dependent kinases

Cellular and molecular life sciences : CMLS, 2001-08, Vol.58 (9), p.1333-1339

2001

Volltextzugriff (PDF)

Identification of somatic hypermutations in the TP53 gene in B-cell chronic lymphocytic leukemia

Molecular immunology, 2008-03, Vol.45 (5), p.1525-1529

2008

Volltextzugriff (PDF)

1.8 MicroRNA Mutational Analysis in Patients with Chronic Lymphocytic Leukemia

Clinical lymphoma, myeloma and leukemia, 2011-10, Vol.11, p.S145-S146

2011

Volltextzugriff (PDF)

ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin

Haematologica (Roma), 2013-07, Vol.98 (7), p.1124-1131

2013

Volltextzugriff (PDF)

666 Analysis of microRNAs associated with aggressive subtype of chronic lymphocytic leukaemia harbouring inactivated p53

European journal of cancer supplements, 2010, Vol.8 (5), p.168-168

2010

Volltextzugriff (PDF)

159 Selection and clinical relevance of monoallelic and biallelic TP53 defects in chronic lymphocytic leukemia

European journal of cancer supplements, 2010, Vol.8 (5), p.42-42

2010

Volltextzugriff (PDF)

The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

British journal of haematology, 2014-08, Vol.166 (4), p.621-625

2014

Volltextzugriff (PDF)

Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants

Klinicka onkologie : casopis Ceske a Slovenske onkologicke spolecnosti, 2019, Vol.32 (Supplementum2), p.51

2019

Volltextzugriff (PDF)

New promoter mutations in the low‐density lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype: Molecular and functional analysis

Journal of inherited metabolic disease, 2004-01, Vol.27 (4), p.523-528

2004

Volltextzugriff (PDF)

Galactosemia: deletion in the 5' upstream region of the GALT gene reduces promoter efficiency

Human genetics, 2001-07, Vol.109 (1), p.117-120

2001

Volltextzugriff (PDF)

5-Methylcytosine as a marker for the monitoring of DNA methylation

Journal of Chromatography B, 2002-12, Vol.781 (1), p.373-392

2002

Volltextzugriff (PDF)

Rare Somatic p53 Mutation Identified in Breast Cancer: A Case Report

Tumor biology, 2001-03, Vol.22 (2), p.59-66

2001

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

Detailed analysis of therapy-driven clonal evolution of TP53 mutations in chronic lymphocytic leukemia

The impact of SF3B1 mutations in CLL on the DNA-damage response

ERIC recommendations on TP53 mutation analysis in chronic lymphocytic leukemia

Targeted next-generation sequencing in chronic lymphocytic leukemia: a high-throughput yet tailored approach will facilitate implementation in a clinical setting

miR-34a, miR-29c and miR-17-5p are downregulated in CLL patients with TP53 abnormalities

The Important Role of STAT3 in Chronic Lymphocytic Leukaemia Biology

TP53 mutation profile in chronic lymphocytic leukemia: evidence for a disease specific profile from a comprehensive analysis of 268 mutations

Assessment of p53 and ATM functionality in chronic lymphocytic leukemia by multiplex ligation-dependent probe amplification

613 Clonal Selection of TP53 Mutations in Chronic Lymphocytic Leukaemia Detected by Ultra-deep Pyrosequencing

885 P53 Mutations Affecting DNA-binding Have Prominent Impact on Survival in Chronic Lymphocytic Leukemia

Inactivation of p53 and deletion of ATM in B-CLL patients in relation to IgVH mutation status and previous treatment

Potent induction of wild-type p53-dependent transcription in tumour cells by a synthetic inhibitor of cyclin-dependent kinases

Identification of somatic hypermutations in the TP53 gene in B-cell chronic lymphocytic leukemia

1.8 MicroRNA Mutational Analysis in Patients with Chronic Lymphocytic Leukemia

ATM mutations uniformly lead to ATM dysfunction in chronic lymphocytic leukemia: application of functional test using doxorubicin

ATM mutations in major stereotyped subsets of chronic lymphocytic leukemia: enrichment in subset #2 is associated with markedly short telomeres

666 Analysis of microRNAs associated with aggressive subtype of chronic lymphocytic leukaemia harbouring inactivated p53

159 Selection and clinical relevance of monoallelic and biallelic TP53 defects in chronic lymphocytic leukemia

The frequency of TP53 gene defects differs between chronic lymphocytic leukaemia subgroups harbouring distinct antigen receptors

Twenty Years of BRCA1 and BRCA2 Molecular Analysis at MMCI - Current Developments for the Classification of Variants

ATM Mutations in Major Stereotyped CLL Subsets: Enrichment in Subset #2 is Associated with Unfavourable Outcome

New promoter mutations in the low‐density lipoprotein receptor gene which induce familial hypercholesterolaemia phenotype: Molecular and functional analysis

Galactosemia: deletion in the 5' upstream region of the GALT gene reduces promoter efficiency

5-Methylcytosine as a marker for the monitoring of DNA methylation

Rare Somatic p53 Mutation Identified in Breast Cancer: A Case Report

Suchergebnisse filtern